Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6015400 | Epilepsy Research | 2015 | 10 Pages |
Abstract
Broad epitope recognition spectrum and delayed production of autoantibodies to NMDA type GluR in CSF of RS patients suggest that the autoantibodies are produced against NMDA type GluR antigens derived from cytotoxic T cell-mediated neuronal damages. These antibodies may impact the pathophysiology of RS in the most active stage, and could be a marker for active inflammation in the clinical course of RS. Further studies including passive transfer of the antibodies to mice may reveal the pivotal roles of the antibodies in RS.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Tetsuhiro Fukuyama, Yukitoshi Takahashi, Yuko Kubota, Yukiko Mogami, Katsumi Imai, Yoshiyuki Kondo, Hiroshi Sakuma, Koji Tominaga, Hirokazu Oguni, Shigeko Nishimura,